HM

Hanumalla Mahender

Director Additional Director DIN 09399514
DIN 09399514 First appointment Nov 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Nov 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Hanumalla Mahender

Data last updated:

Hanumalla Mahender was an Additional Director at Accu Rapid Diagnostic Centre Private Limited (2021–2022). The company operates in Healthcare.

DIN 09399514
Primary Designation Additional Director
Industry Healthcare
First Appointment 15 Nov 2021

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director15 Nov 20212021₹6.59 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Accu Rapid Diagnostic Centre Private Limited
Premium access

Shareholding and investment profile for Hanumalla Mahender

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hanumalla Mahender

Hanumalla Mahender was first appointed on 15 Nov 2021 as Additional Director at Accu Rapid Diagnostic Centre Private Limited.

Hanumalla Mahender held 1 earlier board appointment: Accu Rapid Diagnostic Centre Private Limited (Additional Director, 15 Nov 2021 to 23 May 2022).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available